Pharmascience Faces Six-Year Wait On Canadian Invega Sustenna

Key Canadian Patent Not Obvious And Is Patentable Subject Matter

 
• By Dean Rudge
  
Magnifying Canada on map
Teva had also previously failed on the '335 patent • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin